Silo Pharma Initiates Study of Novel Joint Homing Peptide in Human Tissue

Microdose
Tue, Nov 22
--Silo Pharma, Inc., a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced its plans to initiate a pilot study of its...
Discover